1.McDonald's Corporation
MCD (NYSE)
McDonald's Corporation stands out as a global quick-service restaurant chain with a robust value proposition and defensive characteristics, particularly within the U.S. market. With a dividend yield of 2.79% and a five-year return of 11.11%, it represents an appealing choice for investors seeking reliable income from financially healthy companies. Analysts maintain a median 12-month price target of $308.00, reflecting a cautious outlook with current ratings ranging from Neutral to Buy.
Pros:
- Strong global brand recognition
- Defensive characteristics in fast food
Cons:
- Recent negative returns
- Market competition
2.Coca-Cola Company
KO (NYSE)
Coca-Cola Company remains a beverage staple with robust pricing power and steady demand in the U.S. market. With a dividend yield of 2.33% and impressive returns of 29.55% over the past year and 60.23% over five years, it presents an appealing investment opportunity. Analysts have a median 12-month price target of $95.00, underscoring confidence in its continued performance, with a solid B rating.
Pros:
- Consistent demand for beverages
- Strong pricing power
Cons:
- Market saturation
- Health trends affecting soft drink consumption
3.Colgate-Palmolive Company
CL (NYSE)
Colgate-Palmolive Company, a leading player in consumer staples, focuses on everyday oral and home care products in the U.S. With a solid dividend yield of 2.28% and a strong 5-year return of 17.46%, it presents an attractive option for investors seeking reliable income from financially healthy companies. Analysts maintain a positive outlook, setting a median 12-month price target of $100, supported by ratings from firms like Evercore ISI and UBS.
Pros:
- Strong brand portfolio
- Stable demand for consumer staples
Cons:
- Market competition
- Dependence on consumer spending
4.Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson stands as a diversified healthcare leader, showcasing resilient demand for its medical and consumer health products in the U.S. With a dividend yield of 1.93% and impressive returns of 49.55% over the past year and 52.89% over five years, it remains an attractive option for investors seeking reliable income from financially healthy companies. Analysts maintain a median price target of $282.00, with a strong Buy rating from Guggenheim, indicating confidence in the company's growth trajectory.
Pros:
- Strong dividend growth history
- Resilient demand for healthcare products
Cons:
- Market volatility risk
- Regulatory challenges in the healthcare sector
5.PepsiCo, Inc.
PEP (NASDAQ)
PepsiCo, Inc. offers a diverse array of snacks and beverages, making it a resilient choice for investors, especially during economic downturns in the U.S. Currently, the company has a dividend yield of 4.08%, appealing to those seeking reliable income. Analysts have a median price target of $155, with a range between $134 and $183, reflecting a solid outlook.
Pros:
- Diverse product portfolio
- Strong brand recognition
Cons:
- Recent negative returns
- Market competition
6.Walmart
WMT (NASDAQ)
Walmart stands out as a defensive consumer staples retailer, known for its resilience during economic downturns. Offering a modest dividend yield of 0.95%, it has delivered impressive returns, with a 7.35% gain over the past year and a remarkable 111.18% over the last five years. Analysts maintain a favorable outlook, with a median 12-month price target set at $130.00, indicating strong confidence in its continued performance.
Pros:
- Recession-resistant business model
- Steady demand for consumer staples
Cons:
- Recent negative returns
- Intense competition in retail
7.The Procter & Gamble Company
PG (NYSE)
Procter & Gamble, a household essentials leader, boasts strong brand demand and durable cash flows among U.S. consumers. Ideal for investors seeking consistent income, the company offers a dividend yield of 2.91%, though it has faced a 1-year return of -8.73%. Analysts are cautiously optimistic, with a median 12-month price target of $162 and an overall rating of B+, reflecting a mix of holds and buys from various firms.
Pros:
- Strong brand demand
- Durable cash flows
Cons:
- Recent negative returns
- Market competition
8.Costco Wholesale Corporation
COST (NASDAQ)
Costco Wholesale Corporation stands out as a membership-driven retailer, offering reliable recurring revenue and significant value-oriented demand within the U.S. Despite a modest 1-year return of -0.37%, the stock has delivered an impressive 5-year return of 110.07%. Analysts maintain a median 12-month price target of $1,100, with ratings varying from Overweight to Buy, underscoring its strong market position.
Pros:
- Strong value-oriented demand
- Recurring revenue from memberships
Cons:
- Recent negative returns
- Dependence on consumer spending
Final Words
As you consider your investment options, remember that recession-proof stocks like Johnson & Johnson can provide stability in uncertain times. Take time to compare different opportunities and conduct your own research to ensure your portfolio is well-positioned for the future.
Frequently Asked Questions
Johnson & Johnson has shown impressive returns, with a YTD return of 27.76% and a 1-year return of 49.55%. Over the last 5 years, the company has delivered a return of 52.89%.
Johnson & Johnson pays dividends quarterly. The next dividend payment is scheduled for September 8, 2026, with a distribution of $1.34.
Yes, Johnson & Johnson is considered a good recession-proof stock due to its diversified healthcare offerings and resilient demand for its medical and consumer health products. This stability can help mitigate risks during economic downturns.
As of now, Johnson & Johnson has a market capitalization of approximately $637.15 billion, indicating its significant size and presence in the healthcare sector.
When investing in recession-proof stocks, consider factors like the company's financial stability, its historical performance during economic downturns, and the demand for its products or services. Additionally, evaluate the dividend yield and growth potential.
Johnson & Johnson stands out among healthcare stocks due to its diversified portfolio and consistent performance, including a 3-year return of 60.93%. It frequently receives positive ratings from analysts, which bolsters its reputation in the sector.
